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INTRODUCTION 
 
The neuronal retina is segregated from the systemic 
immune system by the blood retina barriers (BRB) and 
is considered as an immune privileged tissue. In 
addition to the physical barrier, the immune suppressive 
microenvironment of the eye is also critical for retinal 
immune privilege [1-3]. The immune privilege reduces 
the likelihood of intraocular inflammation, thus protects 
the neuroretina from inflammation-mediated damage. 
Despite the lack of systemic immune surveillance, the 
retina is well-protected by its own innate immune 
defence system, including innate immune cells (e.g., 
microglia and perivascular macrophages) and the 
complement system [4]. The pathophysiology of retinal 
innate immune cells, particularly microglia has been 
well-studied and the subject has been reviewed 
extensively recently (see review article [5-7]). However, 
how the complement system protects the retina remains 
poorly defined.   
 
The complement system constitutes over 30 proteins 
and protein fragments. Most of the complement proteins 
are known to be synthesized in the liver and released 
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ABSTRACT 
 
Age-related para-inflammation in the retina-choroidal interface is featured by low-levels of complement 
activation and subretinal macrophage accumulation. This study aimed to understand how complement 
expression in macrophages is regulated by retinal pigment epithelium (RPE). Bone marrow-derived 
macrophages (BMDMs) and RPE cells were cultured from 8-10 weeks old C57BL/6J mice. The BMDMs were co-
cultured with normal RPE, or oxidized photoreceptor outer segment (oxPOS) or TNF-α pre-treated RPE, or 
apoptotic RPE, or RPE-choroid eyecups. Macrophages were then isolated and processed for real-time RT-PCR. 
The expression of complement inhibitor C1INH in BMDMs was significantly upregulated by RPE and RPE-
choroid eyecups. The eyecups also upregulated CFH, CD59a, and Crry in BMDMs. oxPOS pre-treated RPE 
upregulated C1qb but down-regulated C3 expression in BMDMs. TNF-α pre-treated RPE enhanced C1INH and 
CFB expression. When BMDMs were treated with apoptotic RPE, the expression of C1qb, CFH, and CD59a was 
reduced, whereas the expression of C3, CFB and C1INH was increased. Our results suggest that RPE can 
modulate macrophages complement expression at the retina-choroidal interface even under aging or oxidative 
conditions. However, during inflammation, they may promote the alternative pathway of complement 
activation through down-regulating CFH and CD59a and upregulating CFB and C3.  
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into circulation as inactive precursors. Recent evidence 
suggests that complement components are also 
produced outside the liver by tissue cells [8]. Previous 
studies from our group and others have shown that the 
retina and retinal pigment epithelium (RPE)/choroidal 
tissue express a variety of complement components [9-
11], and microglia and RPE are the major sources of 
local complement expression [9,12]. During aging, the 
expression of complement proteins or fragments is 
increased in the retina, particularly at the retina-choroid 
interface [4,11,13,14]. Together with a low level of 
microglial activation, the increased immune reactivity 
in the aging retina (also known as para-inflammation 
[14,15]) maintains retinal homeostasis and functionality 
[14].   
 
The retina-choroid interface undergoes progressive 
changes during aging. For example, RPE cells increase 
in size and become multinucleate [16], phagocytes 
(microglia and macrophages) accumulate in the 
subretinal space (Figure 1) [17-19]. RPE cells and 
macrophages can both produce complement proteins 
[9,12],  and they are the major sources of complement 
expression at the retina-choroid interface in the normal 
aging eye. How their complement expression is 
regulated during aging and at disease conditions is an 
important question. We have shown previously that 
complement expression in RPE cells is regulated by 
active macrophages [12]. We have also shown that 
complement expression in macrophages is regulated by 
cytokines presented at the microenvironment [20]. 
Macrophages are in close contact with RPE cells at the 
subretinal space in the aging eye (Figure 1). The aim of 
this study was, therefore, to investigate how 
complement expression in macrophages is regulated by 
RPE cells.  
 
Under normal physiological conditions, RPE cells can 
suppress macrophage activation through pigment 
epithelial-derived factor (PEDF) [21-23] and α-
melanocyte stimulating hormone (α-MSH) [24]; 
whereas, under disease conditions, particularly when 
RPE cells undergo apoptotic death, the dead RPE cells 
can induce an angiogenic phenotype in macrophages 
[25]. Although substantial RPE death unlikely occurs in 
the normal aging eye, the cells are subjected to chronic 
oxidative stress and are constantly undergoing 
morphological remodeling [16]. The ability of RPE 
cells to modulate macrophage function in the subretinal 
space may depend on the condition of RPE cells. 
Indeed, subretinal macrophages in the healthy adult 
eyes (6 -12 months old) often have a small soma and 
long- fine-dendrites (Fig. 1A), whereas the cells in the 
aging eye (20 – 27 months) have a large cell body that 
often contains pigmented debris (Fig. 1B) [15], and they 
are autofluorescent (Fig. 1C) [17]. This suggests that 
they are active phagocytizing debris released by 
stressed RPE cells. In this study, we investigated the 
effect of different types of RPE cells in macrophage 
complement expression, including normal RPE cells, 
oxidized photoreceptor outer segments (oxPOS) pre-
treated or TNF-α pre-treated RPE cells and apoptotic 
RPE cells.  
 
RESULTS 
 
The effects of normal RPE cells on BMDM 
complement gene expression  
 
Previously we have shown that macrophages express a 
variety of complement components and regulatory 
genes [20]. In this study, we selectively investigated 
complement genes that were expressed at reasonable 
levels in macrophages in our previous study, including 
c1qb and c1inh of the classical pathway, cfb and cfh of 
the alternative pathway, and c3 and cd59a of the 
terminal pathway. When BMDMs were co-cultured 
with normal RPE cells, the expression of C1qb and C3 
mRNA was significantly reduced (Figure 2), whereas 
 
 
Figure 1. Subretinal macrophages in the aging eye. RPE/choroidal flatmount from 18 months (A) and 24 months (B) old 
CX3CR1gfp/+ mice were stained with phalloidin and imaged by confocal microscopy. Arrows - pigmented debris in subretinal 
macrophages. (C), RPE/choroidal flatmount from a 24 month old CX3CR1gfp/+ mouse was imaged by confocal microscopy. Green – GFP+ 
subretinal macrophages; Red – autofluorescence (AF).    
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the mRNA expression of CD59a, particularly C1INH 
was markedly increased (1.85-fold and 53.07-fold 
respectively) (Figure 2A). The upregulation of C1INH 
was further confirmed at protein level by Western Blot 
(Figure 2B, 2C). The expression of CFB and CFH was 
not affected. C1INH and CD59a negatively regulate 
complement activation. Our result suggests that under 
normal physiological conditions, RPE cells may 
suppress complement activation at the retina—choroid 
interface by modulating subretinal macrophage 
complement expression.   
The effects of oxPOS pre-treated RPE cells on 
BMDM complement gene expression  
 
Our recent work suggests that oxidized POS (oxPOS) 
suppresses RPE proliferation and induces 
multinucleation, a phenotype that is similar to RPE cells 
in the aging eye [16]. In this study, we further found 
that oxPOS treatment induced β-galactosidase 
expression in RPE cells (Figure 3A), an indicative of 
cell senescence. When BMDMs were co-cultured with 
oxPOS pre-treated RPE, the expression of C1qb 
 
 
Figure 2. The effects of normal RPE cell on BMDM complement expression. BMDMs from C57BL/6J mice were co-cultured 
with primary mouse RPE cells for 7h (A) or 24h (B). Macrophages were then isolated by CD11b+ MACS kit and processed for real-time 
RT-PCR analysis of complement genes (A) and western blot analysis of C1INH protein expression (B). Fold change of C1INH protein 
expression by BMDMs after co-culture was analyzed by ImageJ (C). Mean ± SEM, n =3; *, P< 0.05; **, P < 0.01 compared to naïve 
BMDM alone, Unpaired Student t test.   
 
 
 
Figure 3. The effects of oxidized POS treated-RPE cell on BMDM complement gene expression. RPE cells were treated with 
oxidized photoreceptor outer segments (oxPOS) for 24h. oxPOS were then removed from the culture. (A) β-galactosidase expression in 
ox-POS-treated RPE cells. (B) The oxPOS pre-treated RPE cells were co-cultured with naïve BMDMs for 7h. Macrophages were isolated 
and processed for real-time RT-PCR analysis of complement genes. Mean ± SEM, n =3; *, P< 0.05; **, P < 0.01 compared to naïve 
BMDM alone, Unpaired Student t test.  
 
www.aging-us.com 4 AGING 
increased by more than 3-fold. The expression of 
C1INH remained at high levels (49.36-fold increment) 
compared with untreated BMDMs, whereas the 
expression of C3 was significantly decreased (Figure 
3B). The expression of other genes, including CFB, 
CFH, and CD59a was not affected (Figure 3B). C1q is 
involved not only in the CP complement activation, but 
also in phagocytosis [26]. Our results suggest that, RPE 
cells in the aging eye may suppress complement 
activation through macrophage related C1INH and 
promote subretinal macrophage phagocytosis by 
enhancing C1q expression.  
 
The effects of TNF-α pre-treated RPE cells on 
BMDM complement gene expression  
 
TNF-α is one of the key inflammatory mediators in the 
inflamed eye e.g., uveoretinitis [27-29]. When BMDMs 
were co-cultured with TNF-α pre-treated RPE cells, the 
expression of CFB and C1INH was increased by 3.7-
fold and 50.1-fold respectively (Figure 4), whereas 
other complement component genes, including C1qb, 
C3, CFH and CD59a remained unchanged (Figure 4). 
The result suggests that under inflammatory conditions, 
RPE cells may convert macrophages into a phenotype 
that can promote complement activation through the 
alternative but not the classical or MBL pathway.   
 
The effects of apoptotic RPE cells on BMDM 
complement gene expression  
 
Apoptotic RPE cells were induced by exposing cells to 
1mM H2O2 in serum-free DMEM overnight at 37°C 
[30]. Flow cytometry analysis confirmed that ~90% 
RPE cells were Annexin V+ or Annexin V+PI+ (Figure 
5A). When BMDMs were incubated with apoptotic 
RPE cells, the expression of C3, CFB and C1INH was 
upregulated by 3.58-fold, 59.63-fold and 45.76-fold 
respectively, whereas the expression of C1q, CFH and 
CD59a was down-regulated to 0.20-fold, 0.03-fold and 
 
 
Figure 5. The effects of apoptotic RPE cell on BMDM complement gene expression. Primary mouse RPE cells were treated 
with H2O2 in serum-free DMEM overnight. Apoptotic RPE cells were confirmed by Propidium iodide (PI) and Annexin V staining (A). The 
apoptotic RPE cells were then incubated with naïve BMDMs for 7h. Macrophages were isolated and processed for real-time RT-PCR 
analysis of complement genes (B). Mean ± SEM, n =3; *, P< 0.05; **, P < 0.01, ***, P < 0.001 compared to naïve BMDM alone, Unpaired 
Student t test.  
 
5  
 
Figure 4. The effects of TNF-α treated-RPE cell on BMDM complement gene expression. RPE cells were treated with TNF-α 
for 16h. Naïve BMDMs were then co-cultured with TNF-α pre-treated RPE cells for 7h. Macrophages were isolated and processed for 
real-time RT-PCR analysis of complement genes. Mean ± SEM, n =3; *, P< 0.05; **, P < 0.01 compared to naïve BMDM alone, Unpaired 
Student t test.  
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0.55-fold (compared to BMDM alone) respectively 
(Figure 5B). The result suggests that apoptotic RPE 
cells may promote AP complement activation in 
subretinal macrophages.  
 
Changes in BMDM complement gene expression 
after culturing in RPE-choroid eyecup 
 
To further understand how complement expression by 
subretinal macrophages is regulated by RPE cells in the 
aging eye, BMDMs were cultured in the eyecups of 18 
months old mice. The cells were then removed from the 
eyecups and their complement gene expression was 
analyzed by real-time RT-PCR. Compared to naive 
BMDMs, the eyecup treated macrophages expressed 
significantly higher levels of CFH, C1INH, CD59a and 
Crry (2~3-fold increment) (Figure 6). There was a trend 
of upregulation in CD55 mRNA in eyecup treated 
macrophages (Figure 6, P = 0.12 respectively). The 
expression of other complement genes, including C1qb, 
C3, C4 and CFB remained unchanged (Figure 6). CFH 
and C1INH are secretory types of complement 
inhibitors, whereas CD59a, Crry and CD55 are 
membrane-type inhibitors. Our results suggest that 
subretinal macrophages are likely to suppress 
complement activation at the retina-choroid interface in 
the normal aging eye.     
 
DISCUSSION 
 
RPE cells are known to critically control the immune 
suppressive microenvironment of the subretinal space 
through multiple mechanisms, including inducing the 
death of infiltrating immune cells (through the Fas 
Ligand and Tumor Necrosis Factor-related apoptosis-
inducing ligand (TRAIL) [31-33]), releasing of immune 
suppressive mediators (e.g. TGF-β, retinoic acid, 
thrombospondin-1, CTLA4 and CLTA2) [34-37]). In 
this study, we show that RPE cells can modulate 
macrophage towards an anti-complement activation 
phenotype although inflammatory or apoptotic RPE 
cells may promote the alternative pathway of 
complement activation by inducing relevant 
complement expression in macrophages. The immune 
modulatory role of RPE cells on macrophage 
complement expression may be an additional 
mechanism to maintain retinal homeostasis particularly 
in the aging eye where macrophages accumulate in the 
subretinal space.  
 
Previously we have reported a low-level of complement 
activation (e.g., increased CFB and C3/C3b expression) 
at the retina-choroid interface in the aging eye [11,14]. 
We believe that this low-level of complement activation 
is beneficial and important to maintain retinal 
homeostasis [14]. Uncontrolled complement activation 
is believed to be involved in the pathogenesis of AMD 
[4,10,38-40]. How complement activation at the 
immune privileged site of subretinal space (i.e., retina-
choroid interface) is regulated and why the activation 
becomes detrimental in AMD is not known. Previous 
studies have observed higher plasma levels of C3a, C4a 
and C5a in AMD patients compared to age-matched 
controls [39-41]. However, a recent study by Schick et 
al did not find significant difference in the plasma levels 
of C3a, Ba, sC5b-9, CFH, CFI between AMD patients 
and age-matched controls, but the aqueous levels of C3a 
and Ba were significantly higher in AMD patients [42], 
suggesting that uncontrolled local but not systemic 
complement activation may play an important role in 
AMD pathogenesis.  
 
RPE and subretinal macrophages are the only two types 
of cells in the retina-choroid interface in the aging eye, 
and they may critically control local complement 
activation. Previously, we have shown that RPE cells 
express high levels of complement regulators (e.g., 
C4BP, MASP1, CFH, C1INH, DAF, Crry and CD59a), 
 
 
Figure 6. The effects of RPE/choroid eye-cup on BMDM complement gene expression. Naïve BMDMs were cultured in 
RPE/choroid eye cup from 18 months old mice for 7h. Macrophages were then isolated and processed for real-time RT-PCR analysis of 
complement genes. Mean ± SEM, n =3; *, P< 0.05; **, P < 0.01 compared to naïve BMDM alone, Unpaired Student t test.  
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but relative low levels of complement components (e.g., 
C2, C4, CFB and C5) [9,12]. This complement 
expression profile fits the immune suppressive nature of 
RPE cells and may contribute to the immune privilege 
of the subretinal space. Macrophages, on the other hand, 
express high levels of C1q under normal culture 
conditions [20]. C1q not only can initiate the classical 
pathway of complement activation, but also is critically 
involved in the phagocytosis of antibody-opsonized or 
FcR coated particles [26]. In this study, we show that 
normal RPE cultures are able to down-regulate the 
expression of C1qb and C3 and upregulate the 
expression of C1INH and CD59a in macrophages. The 
upregulation of complement regulators (CFH, CD59a, 
Crry, C1INH and CD55) was more prominent when 
macrophages were cultured in the RPE-choroid eyecups 
(Figure 6). Our results suggest that RPE cells may 
convert subretinal macrophages into a phenotype that 
can suppress complement activation. This “anti-
complement activation” function of RPE may be a 
novel mechanism contributing to the immune 
suppressive microenvironment of the subretinal space.    
 
The ability of RPE cells to regulate macrophage 
complement expression appears to rely on the 
physiological condition of the cells. After pre-treatment 
with oxPOS which induced RPE cells senescence, RPE 
cells further increased the expression of C1q and 
C1INH in macrophages (Figure 3). This phenotype 
allows macrophages to maintain complement 
suppressive property, but the phagocytosis function may 
be improved (as a result of increased C1q expression). 
oxPOS pre-treated RPE cells mimic the RPE cells in the 
aging eye [16], which may release debris into the 
subretinal space. This macrophage phenotype ensures 
effective clearance of the debris from the subretinal 
space to maintain homeostasis. Indeed, many subretinal 
macrophages in the aging eye contain pigmented 
inclusions (Figure 1B, 1C) [16].  
 
Under disease conditions whereby RPE cells are 
subjected to inflammatory insult (e.g. TNF-α) or even 
undergo cell death, they may lose the immune 
suppressive property, instead become proinflammatory. 
TNF-α pre-treated RPE cells upregulated CFB and 
C1INH expression (Figure 4) in BMDMs, suggesting 
that they may suppress CP but promote AP complement 
activation. This macrophage phenotype was further 
enhanced by apoptotic RPE cells, evidenced by reduced 
expression of CP component (C1q) and AP inhibitor 
(CFH) and increased expression of CP inhibitor 
(C1INH) and AP components (CFB, C3) (Figure 5). 
This result suggests that under disease conditions, 
damaged or dead RPE cells may convert subretinal 
macrophages into a phenotype that can promote the AP 
complement activation at the retina-choroid interface. 
This concept is supported by our previous observation 
that retinal complement activation in autoimmune 
uveoretinitis is mediated predominately by the AP [15]. 
 
In summary, we show that RPE cells can modulate 
macrophage complement expression. Under normal 
aging conditions, RPE cells may convert macrophages 
into a phenotype that can suppress complement 
activation with enhanced phagocytosis. This immune 
regulatory function of RPE cells on macrophages may 
be lost under inflammatory conditions. Instead, 
inflammatory or apoptotic RPE cells promote 
macrophages to produce complement components 
necessary for the AP activation. RPE cells together with 
subretinal macrophages critically control complement 
activation at the retina-choroid interface in the ageing 
eye.  
 
MATERIALS AND METHODS 
 
Preparation of photoreceptor outer segments 
 
Photoreceptor outer segments (POS) were isolated from 
bovine eyes using the sucrose gradient density 
centrifugation as previous described [43]. Oxidized 
POS (ox-POS) was generated by exposing POS to 302 
nm ultraviolet light for 18 hours [43], and lipid 
oxidation was confirmed using thiobarbituric acid 
reactive substance assay (TBARS) kit (OXI-TEK 
TBARS Assay kit, Alexis; Axxora Ltd, Nottingham, 
UK). The levels of TBARS were confirmed to be 60 - 
92 nmol/108 POS in oxPOS and 5 ~ 11 nmol/108 POS in 
non-oxidized POS. 
 
RPE cell culture  
 
Primary mouse RPE cells were isolated and cultured 
from 3-month old wild type C56BL/6J mice as 
described previously [9,11]. Briefly, after removing the 
anterior segment of the eye, the vitreous and retina were 
peeled off from the eye cups. The RPE/choroid/sclera 
eye cups were incubated with 0.5% (w/v) trypsin-EDTA 
(ICN Flow, Irvin, UK) at 37°C for 30 min. RPE cells 
were harvested by gentle aspiration and the single-cell 
suspension was collected and seeded into culture plates 
with Dulbecco’s Modified Eagle Medium (DMEM), 
supplemented with 10% Fetal Calf Serum (FCS) and 
100 mg/ml primocin. Cells were subcultured when they 
reached confluence. RPE phenotype was confirmed by 
their cytokeratin 19 expression. Cells of passage 3-5 
were used for experiments. 
 
To induce apoptosis in RPE cells, the cell cultures were 
treated with 1mM H2O2 in serum-free DMEM for 
overnight at 37°C [30]. Cells were detached by washing 
with ice-cold PBS and processed for Annexin 
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V/Propidium Iodide (PI) staining according to 
manufacturer’s instructions (Life Technologies, UK), 
and examined by FACS Canto II (BD Biosciences, 
Oxford, UK).  
 
To generate oxRPE cells or TNF-α pre-treated RPE 
cells, RPE cells were incubated with 1x 106/ml ox-POS 
[43] or TNF-α (20 ng/ml) [11] for 24 h. Un-ingested 
POS or excessive TNF-α were then removed from the 
culture by thorough washes with warm PBS. RPE cells 
with different treatments were stained for β-
Galactosidase using the Senescence β-Galactosidase 
Staining Kit (Sigma-Aldrich) as per manufacturer’s 
instructions. 
 
Culture of bone marrow-derived macrophages 
(BMDMs)  
 
BMDMs were cultured using the protocol originally 
described by Weischenfeldt and Porse [44] with slight 
modification [20]. Briefly, tibias and femurs were 
collected from 8 to 12-week old wild-type C57BL/6J 
mice. Bone marrow was flushed with DMEM (Gibco 
BRL, Paisley, UK). Red Blood Cells (RBCs) were lysed 
by RBC Lysis Buffer (0.75% NH4Cl, 0.02% Tris-HCl, 
pH 7.2). Cells were then washed and cultured in 
DMEM supplemented with 15% FCS and 15% L929 (a 
murine fibroblast cell line that secretes M-CSF) 
conditioned medium containing 100 mg/ml primocin 
(Invivogen, San Diego, California, USA) in 75 cm2 
Culture Flasks, and incubated at 37°C in 5% CO2 
incubator. After 6 days, cells were collected for further 
experiments. Flow cytometry confirmed that >92% of 
the cells were F4/80+CD11b+.  
 
BMDM-RPE co-culture 
 
1.5 x 106 BMDMs were seeded into T25 flask RPE 
cultures (5 x 105 of normal RPE, or ox-RPE or TNF-α-
RPE or apoptotic RPE cells) and co-cultured for 7h or 
24h. Cells were then detached in ice-cold PBS with 
2mM EDTA and passed through 70 µm cell strainer. 
BMDMs were isolated with the CD11b+ MACS kit 
(Miltenyi Biotec, UK). The phenotype of the BMDMs 
was confirmed to be 95-98% CD11b+F4/80+ by flow 
cytometry (FACS Canto, BD Biosciences, UK). The 
cells were processed further for downstream 
experiments. 
 
Macrophage culture in the eye-cup  
 
Eyes from 18 months old C57BL/6J mice were 
sterilized with 75% ethanol and dissected under 
microscope. The anterior segment of the eye, the lens 
and retinal tissue were removed. The eyecups 
containing RPE, choroid and sclera were used for 
further studies.  
 
1 x 104 BMDMs were added into the eyecup and 
cultured at 37 °C in 5% CO2 incubator for 7h. BMDMs 
on eyecup were harvested by gently shaking the eyecup 
in a tube with culture medium. 90-95% of cells were 
F4/80+ by flow cytometry. The cells were collected and 
processed for real-time RT-PCR. 
 
RNA isolation and reverse transcription 
 
Total RNA was extracted from cultured BMDMs using 
the RNeasy mini kit (Qiagen Ltd., West Sussex, UK) 
according to the manufacturer’s instructions. The 
quantity and quality of the RNA were determined using 
the NanoDrop ND-1000 spectrophotometer (NanoDrop 
Technologies, Wilmington, DE). First-strand cDNA 
synthesis was performed by a reaction of 1 µg of total 
RNA with a random primer, using the SuperScriptTM II 
Reverse Transcriptase kit (Invitrogen, Paisley, UK). 
 
Real-time Polymerase Chain Reaction (Real-time 
RT-PCR) 
 
Real-time RT-PCR was performed in a total of 12 µl 
mixture solution in 384-well plates using the 
LightCycler 480 system (Roche Applied Science, 
Mannheim, Germany). Each 12 µl of reaction mixture 
contains 6 ml of LightCycler 480 SYBR Green Master 
(Roche Diagnostics GmbH, Mannheim, Germany), 0.5 
mM primers and diluted cDNA. Real-time RT-PCR 
quantifications were run in triplicate for each sample 
and the average determined. PCR products were 
quantified by the LightCycler 480 software. Melting 
curve and gel electrophoretic analyses were used to 
determine amplification homogeneity and data quality. 
Expression levels were normalized to β-actin. The 
primer sequences have been described previously 
[12,20]. 
 
Western blot 
 
BMDMs were lysed in RIPA buffer with protease 
inhibitors (Sigma Aldrich, USA). The total protein 
concentration was measured using a BCA kit (Solarbio, 
China). Ten micrograms of total protein were applied to 
10% SDS-PAGE and blotted to an Immobilon-FL 
polyvinylidene difluoride membrane (Millipore, China). 
After blocking with 5% fat-free milk, the membrane 
was incubated with primary antibodies for C1INH 
(Abcam, UK) and β-actin (Arigo Biolaboratories, 
China) at 4 °C overnight, followed by incubation with 
secondary antibodies respectively at room temperature 
for 1-2 h.  Quantitative imaging was performed using 
Odyssey infrared imaging system (Li-COR 
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Biotechnology, USA). Protein bands were quantified 
using ImageJ software. 
 
Data analysis 
 
All data were expressed of Mean ± Standard error of 
mean (SEM). The difference in complement gene 
expression levels between normal un-treated BMDMs 
and different types of RPE treated BMDMs were 
compared using the unpaired Student t test with P < 
0.05 considered to be statistically significant. All 
experiments were repeated at least twice.  
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